Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Barrett

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Stroke|September 1, 1970
Noradrenergic mediation of experimental cerebrovascular spasmR A Fraser, B M Stein, R E Barrett, et al.
Transactions of the American Neurological Association|January 1, 1970
Noradrenergic mediation of experimental cerebrovascular spasmR A Fraser, B M Stein, R E Barrett, et al.
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.
Advances in Neurology|January 1, 1976
Carbamazepine in torsion in dystoniaW P Isgreen, S Fahn, R E Barrett, et al.
The Journal of Small Animal Practice|February 1, 1976
Four cases of congenital portacaval shunt in the dogR E Barrett, A Delahunta, W J Roenick, et al.
Neurology|October 1, 1991
Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiencyS P Stabler, R H Allen, R E Barrett, et al.
Progress in Brain Research|January 1, 1973
Correlation of anatomical and biochemical development of the rabbit neostriatumV M Tennyson, R E Barrett, G Cohen, et al.
Brain Research|November 13, 1972
The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptakeV M Tennyson, R E Barrett, G Cohen, et al.
Transactions of the American Neurological Association|January 1, 1971
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486)M D Yahr, R C Duvoisin, M R Mendoza, et al.
Neurology|September 1, 1979
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapyR P Lesser, S Fahn, S R Snider, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Stroke|September 1, 1970
Noradrenergic mediation of experimental cerebrovascular spasmR A Fraser, B M Stein, R E Barrett, et al.
Transactions of the American Neurological Association|January 1, 1970
Noradrenergic mediation of experimental cerebrovascular spasmR A Fraser, B M Stein, R E Barrett, et al.
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.
Advances in Neurology|January 1, 1976
Carbamazepine in torsion in dystoniaW P Isgreen, S Fahn, R E Barrett, et al.
The Journal of Small Animal Practice|February 1, 1976
Four cases of congenital portacaval shunt in the dogR E Barrett, A Delahunta, W J Roenick, et al.
Neurology|October 1, 1991
Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiencyS P Stabler, R H Allen, R E Barrett, et al.
Progress in Brain Research|January 1, 1973
Correlation of anatomical and biochemical development of the rabbit neostriatumV M Tennyson, R E Barrett, G Cohen, et al.
Brain Research|November 13, 1972
The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptakeV M Tennyson, R E Barrett, G Cohen, et al.
Transactions of the American Neurological Association|January 1, 1971
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486)M D Yahr, R C Duvoisin, M R Mendoza, et al.
Neurology|September 1, 1979
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapyR P Lesser, S Fahn, S R Snider, et al.
Pageof 4